Latest filing published 21 Sept 2016 for Sarepta Therapeutics, Inc., €41k.
Insider track record
Jayant Aphale: trading record in brief
This profile gathers the share dealings of Jayant Aphale in Sarepta Therapeutics, Inc. Over a trading history stretching from 12 November 2013 to 19 September 2016, the count stands at 7 filings.
The open-market record consists of 3 sales worth €1.7M, with no purchase. The rest of the record consists of 2 share grants and 2 option exercises. Since January 2016: no purchases and 2 sales on the market.
The record was last updated on 21 September 2016 with an option exercise (€41k) in Sarepta Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Jayant Aphale
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,000 shares@ US$4.622.4% of flowCommon StockSEC:0001209191-16-142359:0
- 10,000 shares@ US$50.0025.9% of flowCommon StockSEC:0001209191-16-142359:1
- 25,000 shares@ US$4.626.0% of flowCommon StockSEC:0001209191-16-142359:2
- 25,000 shares@ US$50.0064.7% of flowCommon StockSEC:0001209191-16-142359:3
- 765 shares@ US$26.071.0% of flowCommon StockSEC:0001209191-16-139793:0
- 2,352 shares0Common StockSEC:0001209191-16-104941:0
- 15,933 shares@ US$12.56Common StockSEC:0001181431-13-059150:0
7 of 7 declarations
